Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

about

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

Item

http://www.wikidata.org/entity/Q51766017

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

@en

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

@nl

type

Item

label

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

@en

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

@nl

prefLabel

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

@en

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

@nl

P1476

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

@en

P2093

Helen R Griffiths

http://www.w3.org/2001/XMLSchema#string

M Cristina Polidori

http://www.w3.org/2001/XMLSchema#string

P2860

Statins for the treatment of dementia

Dopant assisted-atmospheric pressure photoionization (DA-APPI) liquid chromatography-mass spectrometry for the quantification of 27-hydroxycholesterol in plasma.

Oxysterols and their cellular effectors.

Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia.

Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities.

Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study.

Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease.

Plasma oxysterol level in patients with coronary artery stenosis and its changes in response to the treatment with atorvastatin.

Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

P304

139-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.REDOX.2018.02.014

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29501047

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

5952874

http://www.w3.org/2001/XMLSchema#string